Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06380075 · ClinicalTrials.gov registry record · NA
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
A NA study of Retinal Disease, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06380075 is a NA study of Retinal Disease that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants, below the 1,239-participant average among 19 other Retinal Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06380075, a NA study of Retinal Disease, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retinal diseases (IRDs). Participants will: * undergo pupillary dilation * have photographs taken of the inside of the eyes using three different cameras
Conditions Studied
Interventions
- DEVICE Spectralis FAF imaging
- DEVICE Optos imaging
- DEVICE Clarus imaging
Study Locations (1)
Wisconsin
- Department of Ophthalmology and Visual Sciences - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-08-29 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06380075
The ClinicalTrials.gov registry entry for NCT06380075 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,239-participant average among 19 other Retinal Disease trials with a reported enrollment target (96% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinal Disease appearing as the primary indexed condition, and to 3 interventions - of which Spectralis FAF imaging is the first listed.
NCT06380075 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06380075 about?
NCT06380075 is a clinical study titled "COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease". The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retin...
What is the current status of trial NCT06380075?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-08-29. Estimated completion is 2026-12.
What conditions does trial NCT06380075 study?
This clinical trial studies the following conditions: Retinal Disease.
What interventions are being tested in trial NCT06380075?
The interventions under investigation include: Spectralis FAF imaging (DEVICE), Optos imaging (DEVICE), Clarus imaging (DEVICE).
Who is sponsoring clinical trial NCT06380075?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06380075 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
P200TxE Diseased Eye Image Collection
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
RECRUITING
-
Data Gathering for A10900
RECRUITING
-
Inherited Retinal Degenerative Disease Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.